Covered recipient · General Payments record
IRA A VIDOR
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,603.17
- Reported across 139 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $562.92 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $462.92 | 27 |
| REVANCE THERAPEUTICS, INC. | $54.77 | 2 |
| Tarsus Pharmaceuticals, Inc. | $25.47 | 1 |
| Merz Pharmaceuticals, LLC | $19.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $8.94 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733521 | CMS |
| Amgen Inc. | $6.69 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733513 | CMS |
| Amgen Inc. | $8.51 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733517 | CMS |
| Amgen Inc. | $8.34 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733523 | CMS |
| Amgen Inc. | $28.56 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733515 | CMS |
| Amgen Inc. | $8.45 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733519 | CMS |
| Amgen Inc. | $7.57 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733525 | CMS |
| Amgen Inc. | $9.10 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733527 | CMS |
| Amgen Inc. | $11.05 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733529 | CMS |
| Amgen Inc. | $8.87 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733531 | CMS |
| Amgen Inc. | $121.63 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733541 | CMS |
| Amgen Inc. | $10.60 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733533 | CMS |
| Amgen Inc. | $28.78 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733535 | CMS |
| Amgen Inc. | $8.86 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733539 | CMS |
| Amgen Inc. | $9.27 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733537 | CMS |
| Amgen Inc. | $7.16 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733543 | CMS |
| Amgen Inc. | $9.40 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733549 | CMS |
| Amgen Inc. | $19.75 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733545 | CMS |
| Amgen Inc. | $17.10 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733547 | CMS |
| Amgen Inc. | $24.37 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733551 | CMS |
| Amgen Inc. | $18.46 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733553 | CMS |
| Amgen Inc. | $13.26 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733561 | CMS |
| Amgen Inc. | $11.00 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733555 | CMS |
| Amgen Inc. | $9.57 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733557 | CMS |
| Amgen Inc. | $12.02 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733563 | CMS |
| Amgen Inc. | $9.21 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733559 | CMS |
| Amgen Inc. | $26.40 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111733565 | CMS |
| Merz Pharmaceuticals, LLC | $19.76 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137949774 | CMS |
| REVANCE THERAPEUTICS, INC. | $29.48 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931231 | CMS |
| REVANCE THERAPEUTICS, INC. | $25.29 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147931233 | CMS |
| Tarsus Pharmaceuticals, Inc. | $25.47 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139138742 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.